|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice.
The initial diagnosis of epilepsy is often devastating for families. The patient and parents must be helped to understand the nature of epilepsy and its management, including etiology, prognosis, safety issues and treatment options. The goal of this presentation is to provide pharmacists with knowledge and tools to serve this patient population and their families.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
- Describe clinical features of rare diseases associated with seizures and epilepsy in children.
- Discuss current outpatient treatment options and future trends in therapy.
- Evaluate the role of a specialty pharmacy to coordinate medication access and provide education.
Jennifer Howder, PharmD, BCOP
Clinical Pharmacist – Rare Disease/Neurology
Justin Woods, PharmD
Pharmacy Manager, Richmond
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Jennifer Howder and Justin Woods have no relevant commercial or financial relationships to disclose.
Release Date: 10-15-2019
Expiration Date: 10-15-2022
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-19-500-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 0.5 contact hour (0.05 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.